IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
SPP1 |
P10451
|
secreted phosphoprotein 1
|
|
2.1E-06 |
0.353 |
0.885 |
NOS3 |
P29474
|
nitric oxide synthase 3
|
|
6.7E-07 |
0.378 |
0.885 |
IL1RN |
P18510
|
interleukin 1 receptor antagonist
|
|
3.1E-02 |
0.373 |
0.923 |
THBS1 |
P07996
|
thrombospondin 1
|
|
1.00 |
0.407 |
0.885 |
JAG1 |
P78504
|
jagged canonical Notch ligand 1
|
|
1.00 |
0.429 |
0.808 |
ENG |
P17813
|
endoglin
|
|
1.00 |
0.446 |
0.846 |
COL18A1 |
P39060
|
collagen type XVIII alpha 1 chain
|
|
1.7E-10 |
0.449 |
0.808 |
NES |
P48681
|
nestin
|
|
1.6E-06 |
0.450 |
0.808 |
SMS |
P52788
|
spermine synthase
|
|
0.97 |
0.491 |
0.846 |
PCYT1A |
P49585
|
phosphate cytidylyltransferase 1, choline, alpha
|
|
2.0E-05 |
0.485 |
0.885 |
CERNA3 |
|
competing endogenous lncRNA 3 for miR-645
|
|
|
0.531 |
0.808 |
COL4A2 |
P08572
|
collagen type IV alpha 2 chain
|
|
3.6E-15 |
0.563 |
0.654 |
RSS |
|
Russell Silver syndrome
|
|
|
0.578 |
0.692 |
PDCD10 |
Q9BUL8
|
programmed cell death 10
|
|
0.96 |
0.631 |
0.692 |
SMG8 |
Q8ND04
|
SMG8 nonsense mediated mRNA decay factor
|
|
7.3E-03 |
0.780 |
0.346 |
PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |
MMP2 |
P08253
|
matrix metallopeptidase 2
|
Enzyme
|
0.84 |
0.333 |
0.923 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
SLPI |
P03973
|
secretory leukocyte peptidase inhibitor
|
Enzyme modulator
|
9.0E-04 |
0.449 |
0.846 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
FLT1 |
P17948
|
fms related receptor tyrosine kinase 1
|
Kinase
|
1.00 |
0.419 |
0.846 |